covid 19 News and Research

RSS

Early tracheotomy shortens ICU stay and lowers risk of ventilator-associated pneumonia

Surgically opening the windpipe, or trachea, within the first seven days of the start of mechanical ventilation decreases the time patients spend on ventilators, shortens their ICU stay and lowers their risk of ventilator-associated pneumonia, according to a systematic review published Thursday (March 11) in JAMA Otolaryngology-Head & Neck Surgery.

11 Mar 2021

NCCN publishes new guidance for management of COVID-19 in cancer patients

The National Comprehensive Cancer Network--an alliance of leading cancer centers--has published new best practice recommendations for Management of COVID-19 Infection in Patients with Cancer.

11 Mar 2021

Henry Ford Cancer Institute launches new initiative to improve minority participation in clinical trials

Henry Ford Cancer Institute is launching the Participatory Action for Access to Clinical Trials (PAACT) project to dramatically improve the representation of the African American community and other minorities in cancer clinical trials.

11 Mar 2021

Jobs with greater risk for COVID-19 exposure have high number of Black or Hispanic workers

Black and Hispanic people experience a higher risk for COVID-19 and severe illness, influenced by factors such as discrimination, housing, and healthcare access and utilization.

11 Mar 2021

Study reveals how lung alveolus forms at cellular level

Researchers from Children's Hospital of Philadelphia have determined what happens at a cellular level as the lung alveolus forms and allows newborns to breathe air.

11 Mar 2021

KHN’s ‘What the Health?’: Expanding the ACA in an unpredicted way

For the first time since its enactment in 2010, the Affordable Care Act is slated for major benefit expansions, courtesy of the covid relief bill approved by Congress this week. But the changes are only temporary, so the measure also tees up a fight to make them permanent.

11 Mar 2021

People previously infected with SARS-CoV-2 may achieve immunity after one mRNA vaccine dose, finds study

A team of researchers led by Thomas W. McDade of Northwestern University suggests people who were previously infected with SARS-CoV-2, the causative agent of COVID-19, may require only one dose of the mRNA vaccine to obtain immunity.

11 Mar 2021

Study finds limited association between vitamin D and improved COVID-19 outcomes

New research shows a lack of an association between Vitamin D deficiency and the number of COVID-19 cases, recoveries, or mortality rates in European countries.

11 Mar 2021

High obesity rates in Southern states magnify Covid threat

In January, as Mississippi health officials planned for their incoming shipments of covid-19 vaccine, they assessed the state's most vulnerable: health care workers, of course, and elderly people in nursing homes.

11 Mar 2021

SARS-CoV-2 can infect blood monocytes and trigger inflammation, finds study

Researchers found about 10% of blood monocytes in coronavirus disease 2019 (COVID-19) patients are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). These monocytes then die, leading to the release of cytokines – a feature associated with severe and critical COVID-19.

11 Mar 2021

Promega launches XpressAmp™ Direct Amplification Reagents

Promega Corporation has released XpressAmp™ Direct Amplification Reagents that facilitate RNA extraction-free sample preparation that is automation-friendly.

From Promega Corporation 11 Mar 2021

World Sepsis Congress 2021—watch on-demand

In continuation of Radiometer’s commitment to the fight against sepsis – one of the world’s deadliest diseases - Radiometer is a proud sponsor of World Sepsis Congress.

From Radiometer Medical 11 Mar 2021

Is a single mRNA COVID-19 vaccine dose enough for recovered individuals?

A new study deals with the evaluation of adaptive immune response to COVID-19 vaccination in candidates who have recovered from SARS-CoV-2 infection.

11 Mar 2021

Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies

To address the need for a high-quality neutralization assay against SARS-CoV-2, researchers from the NIAID modified and optimized a previously established fluorescence reduction neutralization assay (FRNA) to provide a quantitative assessment of a large number of infected cells through the use of a high-content imaging system.

11 Mar 2021

Pregnant women in Japan had higher levels of anxiety during COVID-19 pandemic

Pregnant women in Japan who responded to an online survey early in the COVID-19 pandemic demonstrated higher levels of anxiety compared to women undergoing fertility treatments and to pregnant women in Iran.

11 Mar 2021

Nanobody works against all SARS-CoV-2 variants of concern in animal model

Researchers based in Belgium have developed a new antibody drug that is highly successful at neutralizing coronavirus disease 2019 (COVID-19) in Syrian hamsters. The new biologic was administered to the rodents and was found to be equally successful at neutralizing the original severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain, and also the new mutant variants, such as the South African and UK strains.

11 Mar 2021

Music-based interventions can improve stroke, Parkinson's disease

Music-based interventions have become a core ingredient of effective neurorehabilitation in the past 20 years thanks to the growing body of knowledge.

11 Mar 2021

Brazil COVID variant 2.5 times more transmissible than ancestral strain

In early January 2021, a new variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified from travelers returning from Brazil. This variant, referred to as “P.1”, likely emerged in early-to-late November 2020, and subsequently spread throughout Manaus, the state capital of Amazonas, Brazil, over the following December.

11 Mar 2021

SARS-CoV-2 spike S1 subunit induces hypercoagulability

The vascular complications of the condition include a range of various coagulopathies that cause bleeding and thrombocytopenia or a hypercoagulable state. A new preprint research paper posted to the medRxiv server describes the role of a fibrinogen-related protein in inducing these clinical features of COVID-19.

10 Mar 2021

Study assesses COVID-19 policy differences between GOP- and Democrat-led states

The per-capita rates of new COVID-19 cases and COVID-19 deaths were higher in states with Democrat governors in the first months of the pandemic last year, but became much higher in states with Republican governors by mid-summer and through 2020, possibly reflecting COVID-19 policy differences between GOP- and Democrat-led states, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health and the Medical University of South Carolina.

10 Mar 2021